首页> Pediatric Hematology and Oncology> Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.

Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.

导出原文传递

翻译打印收藏纠错

作者： Manoura A ^[1] ; Korakaki E ; Hatzidaki E ; Saitakis E ; Maraka S ; Papamastoraki I ; Matalliotakis E ; Foundouli K ; Giannakopoulou C

作者单位： Department of Neonatology, University of Crete, Crete, Greece. ^[1]

关键词 Adult Erythroblastosis Fetal Erythropoietin Recombinant Female Hematinics 成年人幼红细胞增多症胎儿红细胞生成素重组补血药婴儿新生 Kell血型系统

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pediatric Hematology and Oncology

2007年24卷1期

69-73页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Pediatric Hematology and Oncology

2007年24卷1期

69-73页

检索历史清除

Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.

Pediatric Hematology and Oncology

相似文献

Pediatric Hematology and Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.

Pediatric Hematology and Oncology

相似文献

Pediatric Hematology and Oncology

相关期刊

检索历史清除